21 April 2005
International Brand Licensing plc
('IBL' or the 'Company')
Directorate Change
International Brand Licensing plc is delighted to announce the appointment of
Gordon Hall as a Non-Executive Director of the Company. Gordon has extensive
public company experience, which, the Board believes, will be of great benefit
to IBL and its shareholders moving forward.
Michael Henry, a current Non-Executive Director of IBL, today steps down from
the Board in order to pursue his other business interests. The Company thanks
him for his contribution to the successful development of IBL over the past
three years and wishes him well for the future.
Information concerning Gordon Hall
Full Name: Gordon James Hall
Age: 62
Current directorships Past directorships
FirstAfrica Oil Plc Bio Stat Limited
Osmetech Aesop Trustee Limited GGEM Limited
Osmetech Plc Ntera Limited
Table Mountain Minerals Plc
Save for the above there is no further information required for disclosure
under paragraph (f) of Schedule 2 of the AIM Rules, with respect to the
appointment of Gordon Hall.
-Ends-
For further information please contact,
Adam Reynolds, Director
International Brand Licensing plc
Tel. 020 7823 1733
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.